FitLife Brands Pre-Tax Profit Margin 2010-2025 | FTLF
FitLife Brands pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| FitLife Brands Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.06B | $0.01B | 18.75% |
| 2024-12-31 | $0.07B | $0.01B | 18.46% |
| 2024-09-30 | $0.06B | $0.01B | 17.46% |
| 2024-06-30 | $0.06B | $0.01B | 16.39% |
| 2024-03-31 | $0.06B | $0.01B | 16.95% |
| 2023-12-31 | $0.05B | $0.01B | 15.09% |
| 2023-09-30 | $0.05B | $0.01B | 15.56% |
| 2023-06-30 | $0.04B | $0.01B | 17.95% |
| 2023-03-31 | $0.03B | $0.01B | 18.75% |
| 2022-12-31 | $0.03B | $0.01B | 25.00% |
| 2022-09-30 | $0.03B | $0.01B | 26.67% |
| 2022-06-30 | $0.03B | $0.01B | 24.14% |
| 2022-03-31 | $0.03B | $0.01B | 24.14% |
| 2021-12-31 | $0.03B | $0.01B | 25.00% |
| 2021-09-30 | $0.03B | $0.01B | 22.22% |
| 2021-06-30 | $0.03B | $0.01B | 25.93% |
| 2021-03-31 | $0.02B | $0.01B | 22.73% |
| 2020-12-31 | $0.02B | $0.00B | 18.18% |
| 2020-09-30 | $0.02B | $0.00B | 15.79% |
| 2020-06-30 | $0.02B | $0.00B | 11.76% |
| 2020-03-31 | $0.02B | $0.00B | 15.79% |
| 2019-12-31 | $0.02B | $0.00B | 15.79% |
| 2019-09-30 | $0.02B | $0.00B | 15.00% |
| 2019-06-30 | $0.02B | $0.00B | 10.00% |
| 2019-03-31 | $0.02B | $0.00B | 5.26% |
| 2018-12-31 | $0.02B | 0 | 0.00% |
| 2018-09-30 | $0.02B | $-0.01B | -47.06% |
| 2018-06-30 | $0.02B | $-0.01B | -56.25% |
| 2018-03-31 | $0.02B | $-0.01B | -58.82% |
| 2017-12-31 | $0.02B | $-0.01B | -55.56% |
| 2017-09-30 | $0.02B | $0.00B | -16.67% |
| 2017-06-30 | $0.02B | $0.00B | -10.53% |
| 2017-03-31 | $0.02B | 0 | 0.00% |
| 2016-12-31 | $0.03B | $0.00B | 4.00% |
| 2016-09-30 | $0.03B | 0 | 0.00% |
| 2016-06-30 | $0.03B | 0 | 0.00% |
| 2016-03-31 | $0.02B | $0.00B | -4.55% |
| 2015-12-31 | $0.02B | $0.00B | -11.11% |
| 2015-09-30 | $0.02B | $0.00B | -5.88% |
| 2015-06-30 | $0.02B | 0 | 0.00% |
| 2015-03-31 | $0.02B | $0.00B | 5.88% |
| 2014-12-31 | $0.02B | $0.00B | 10.53% |
| 2014-09-30 | $0.02B | $0.00B | 14.29% |
| 2014-06-30 | $0.02B | $0.00B | 14.29% |
| 2014-03-31 | $0.02B | $0.00B | 15.00% |
| 2013-12-31 | $0.02B | $0.00B | 15.00% |
| 2013-09-30 | $0.02B | $0.00B | 15.79% |
| 2013-06-30 | $0.02B | $0.00B | 10.53% |
| 2013-03-31 | $0.02B | $0.00B | 10.53% |
| 2012-12-31 | $0.02B | $0.00B | 11.11% |
| 2012-09-30 | $0.02B | $0.00B | 11.11% |
| 2012-06-30 | $0.02B | $0.00B | 12.50% |
| 2012-03-31 | $0.01B | $0.00B | 7.14% |
| 2011-12-31 | $0.01B | 0 | 0.00% |
| 2011-09-30 | $0.01B | $0.00B | 18.18% |
| 2011-06-30 | $0.01B | $0.00B | 40.00% |
| 2011-03-31 | $0.01B | $0.01B | 66.67% |
| 2010-12-31 | $0.01B | $0.01B | 100.00% |
| 2010-09-30 | $0.01B | $0.01B | 100.00% |
| 2010-06-30 | $0.01B | $0.01B | 100.00% |
| 2010-03-31 | $0.01B | $0.01B | 100.00% |
| 2009-12-31 | $0.01B | $0.01B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.130B | $0.064B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.835B | 28.36 |
| Boston Scientific (BSX) | United States | $157.798B | 39.50 |
| Stryker (SYK) | United States | $150.649B | 31.50 |
| EssilorLuxottica (ESLOY) | France | $134.205B | 0.00 |
| Medtronic (MDT) | Ireland | $111.543B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.908B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.033B | 27.90 |
| ResMed (RMD) | United States | $37.148B | 27.90 |
| GE HealthCare Technologies (GEHC) | United States | $33.471B | 15.89 |
| Agilent Technologies (A) | United States | $32.342B | 21.36 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $22.931B | 90.01 |
| Koninklijke Philips (PHG) | Netherlands | $22.436B | 16.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 12.17 |
| Baxter (BAX) | United States | $16.150B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.745B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.414B | 13.66 |
| Prestige Consumer Healthcare (PBH) | United States | $4.395B | 19.63 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.484B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.396B | 25.05 |
| Envista Holdings (NVST) | United States | $3.000B | 24.93 |
| QuidelOrtho (QDEL) | United States | $2.203B | 15.15 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.942B | 43.41 |
| AtriCure (ATRC) | United States | $1.604B | 0.00 |
| Neogen (NEOG) | United States | $1.389B | 17.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.245B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.213B | 12.31 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| BioLife Solutions (BLFS) | United States | $1.090B | 0.00 |
| InMode (INMD) | Israel | $1.011B | 9.25 |
| Phibro Animal Health (PAHC) | United States | $0.978B | 12.50 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.638B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.566B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.474B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.330B | 12.14 |
| Canopy Growth (CGC) | Canada | $0.302B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 50.20 |
| Sanara MedTech (SMTI) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| Sanuwave Health (SNWV) | United States | $0.253B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.41 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.102B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.81 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.060B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.69 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.71 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |